Chinese Dragon’s Blood EtOAc Extract Inhibits Liver Cancer Growth Through Downregulation of Smad3

Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies, which ranks the third leading cause of cancer-related death worldwide. The screening of anti-HCC drug with high efficiency and low toxicity from traditional Chinese medicine (TCM) has attracted more and more attention. As a TC...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xiaonan, Zhao, Yanan, Yang, Ailin, Tian, Yingying, Pang, Daoran, Sun, Jing, Tang, Leimengyuan, Huang, Huiming, Wang, Ying, Zhao, Yunfang, Tu, Pengfei, Hu, Zhongdong, Li, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237706/
https://www.ncbi.nlm.nih.gov/pubmed/32477135
http://dx.doi.org/10.3389/fphar.2020.00669

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237706/
https://www.ncbi.nlm.nih.gov/pubmed/32477135
http://dx.doi.org/10.3389/fphar.2020.00669

Ejemplares similares